Shares of Moderna rose 4.35% to $159.15 at 10:16 EST on Monday, after two successive sessions in a row of gains. The Nasdaq Stock Market is jumping 0.7% to $12,464.20, after two successive sessions in a row of gains, on what up until now seems, a somewhat positive trend exchanging session today.
Moderna’s last close was $157.26, 12.16% under its 52-week high of $178.50.
News about Moderna today
Early bet on Moderna sees top european fund gain 65% this year. According to today’s article on Bloomberg Quint, “A Baillie Gifford & Co. health care fund run by an all-female team has surged past peers to a 65% gain this year, largely thanks to a far-sighted bet on medical stock Moderna Inc.”
Moderna’s Sales
Moderna’s sales growth is 1428.1% for the ongoing quarter and 12348.6% for the next. The company’s growth estimates for the current quarter is a negative 48.6% and positive 528.6% for the next.
Moderna’s Revenue
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Top and Bottom Yearly Value
Moderna’s stock is valued at $159.15 at 10:16 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s worth is way higher than its 50-day moving average of $88.87 and way above its 200-day moving average of $73.28.
